BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35178834)

  • 1. E2F1-mediated AUF1 upregulation promotes HCC development and enhances drug resistance via stabilization of AKR1B10.
    Zhang T; Guan G; Zhang J; Zheng H; Li D; Wang W; Lu F; Chen X
    Cancer Sci; 2022 Apr; 113(4):1154-1167. PubMed ID: 35178834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AUF1 promotes hepatocellular carcinoma progression and chemo-resistance by post-transcriptionally upregulating alpha-fetoprotein expression.
    Zhang J; Zhang T; Guan G; Wen J; Chen CC; Liu J; Duan Y; Liu Y; Chen X
    Pathol Res Pract; 2023 May; 245():154441. PubMed ID: 37060820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.
    Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC
    Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16( INK4a) positively regulates cyclin D1 and E2F1 through negative control of AUF1.
    Al-Khalaf HH; Colak D; Al-Saif M; Al-Bakheet A; Hendrayani SF; Al-Yousef N; Kaya N; Khabar KS; Aboussekhra A
    PLoS One; 2011; 6(7):e21111. PubMed ID: 21799732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
    Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aldo-keto reductase family 1 B10 participates in the regulation of hepatoma cell cycle through p27/p-Rb signaling pathway].
    Geng N; Jin YY; Zhu SX; Li YR; Zheng LY; Zhu WJ; Li YW; Han C; Dou XG; Bai H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):861-867. PubMed ID: 33105932
    [No Abstract]   [Full Text] [Related]  

  • 7. Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression.
    Kang J; Huang X; Dong W; Zhu X; Li M; Cui N
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S257-S268. PubMed ID: 34420405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.
    Liu TA; Jan YJ; Ko BS; Wu YJ; Lu YJ; Liang SM; Liu CC; Chen SC; Wang J; Shyue SK; Liou JY
    Oncotarget; 2015 Nov; 6(36):38967-82. PubMed ID: 26516929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma.
    Cheng BY; Lau EY; Leung HW; Leung CO; Ho NP; Gurung S; Cheng LK; Lin CH; Lo RC; Ma S; Ng IO; Lee TK
    Cancer Res; 2018 May; 78(9):2332-2342. PubMed ID: 29483095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between 3' untranslated region of calcitonin receptor messenger ribonucleic acid (RNA) and adenylate/uridylate (AU)-rich element binding proteins (AU-rich RNA-binding factor 1 and Hu antigen R).
    Yasuda S; Wada S; Arao Y; Kogawa M; Kayama F; Katayama S
    Endocrinology; 2004 Apr; 145(4):1730-8. PubMed ID: 14715706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
    Sato S; Genda T; Hirano K; Tsuzura H; Narita Y; Kanemitsu Y; Kikuchi T; Iijima K; Wada R; Ichida T
    Liver Int; 2012 Oct; 32(9):1382-90. PubMed ID: 22681639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells.
    Liu Z; Yan R; Al-Salman A; Shen Y; Bu Y; Ma J; Luo DX; Huang C; Jiang Y; Wilber A; Mo YY; Huang MC; Zhao Y; Cao D
    Biochem J; 2012 Mar; 442(2):273-82. PubMed ID: 22329800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
    Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.
    Sato S; Genda T; Ichida T; Murata A; Tsuzura H; Narita Y; Kanemitsu Y; Ishikawa S; Kikuchi T; Mori M; Hirano K; Iijima K; Wada R; Nagahara A; Watanabe S
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1315-22. PubMed ID: 26758591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of AUF1 is involved in the proliferation of esophageal squamous cell carcinoma through GCH1.
    Gao Y; Wang W; Cao J; Wang F; Geng Y; Cao J; Xu X; Zhou J; Liu P; Zhang S
    Int J Oncol; 2016 Nov; 49(5):2001-2010. PubMed ID: 27826622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AU-binding factor 1 expression was correlated with metadherin expression and progression of hepatocellular carcinoma.
    Yang Y; Kang P; Gao J; Xu C; Wang S; Jin H; Li Y; Liu W; Wu X
    Tumour Biol; 2014 Mar; 35(3):2747-51. PubMed ID: 24213928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis.
    Vázquez-Chantada M; Fernández-Ramos D; Embade N; Martínez-Lopez N; Varela-Rey M; Woodhoo A; Luka Z; Wagner C; Anglim PP; Finnell RH; Caballería J; Laird-Offringa IA; Gorospe M; Lu SC; Mato JM; Martínez-Chantar ML
    Gastroenterology; 2010 May; 138(5):1943-53. PubMed ID: 20102719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autotaxin Expression Is Regulated at the Post-transcriptional Level by the RNA-binding Proteins HuR and AUF1.
    Sun S; Zhang X; Lyu L; Li X; Yao S; Zhang J
    J Biol Chem; 2016 Dec; 291(50):25823-25836. PubMed ID: 27784781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions.
    Matkowskyj KA; Bai H; Liao J; Zhang W; Li H; Rao S; Omary R; Yang GY
    Hum Pathol; 2014 Apr; 45(4):834-43. PubMed ID: 24656094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, China.
    Qi LN; Li LQ; Chen YY; Chen ZH; Bai T; Xiang BD; Qin X; Xiao KY; Peng MH; Liu ZM; Liu TW; Qin X; Li S; Han ZG; Mo ZN; Santella RM; Winkler CA; O'Brien SJ; Peng T
    PLoS One; 2013; 8(12):e83465. PubMed ID: 24391771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.